Abbott Laboratories (NYSE:ABT) share price soared 0.72% or +0.32 points to reach at $45.01 during previous trading session. The stock’s price fluctuated within the range of $44.54 – $45.15 during previous trading session. A total of 11,059,400 shares exchanged hands, whereas the company’s average trading volume stands at 9.28M shares. Abbott Laboratories (NYSE:ABT) has a market capitalization of $78.64B and most recently 1.73B outstanding shares have been calculated.
In terms of market analysis and trading signals, RSI moving above the horizontal 30 reference level is viewed as a bullish indicator, while the RSI moving below the horizontal 70 reference level is seen to be a bearish indicator. Movements above 70 are interpreted as indicating overbought conditions; conversely, movements under 30 reflect oversold conditions.
Relative strength index (RSI-14) for Abbott Laboratories (NYSE:ABT) is at 84.51.
According to sentiments of 13 analysts the mean estimates of short term price target for the company’s stock is marked at $47.46. The most optimistic analyst sees the stock reaching $51.00 while the most conventional predicts the target price at $41.00.
The consensus mean EPS for the current quarter is at $0.43 derived from a total of 14 estimates. According to analysts minimum EPS for the current quarter is expected at $0.43 and can go high up to $0.43. However a year ago during same quarter Abbott Laboratories (NYSE:ABT) reported $0.41 EPS.
For the upcoming quarter, initial predictions are anticipating that the company will post earnings of $0.6 per share according to consensus of 14 analysts.
According to sentiments of 13 analysts the company is expected to report revenues of $6.16B for the current quarter. Bearish revenue estimates established at $6.01B while the bullish revenue forecast has been figured out at $6.36B.
In terms of Buy/Sell recommendations, analysts have a consensus rating of 1.82 on the shares of Abbott Laboratories (NYSE:ABT). Out of rating recommendations 7 have given the stock a Buy while 6 recommend the stock as Outperform. 4 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.
On technical side, moving averages may help to distinguish direction of tendencies, and they might also be used to set levels of sustenance and resistance. Abbott Laboratories (NYSE:ABT)’s distance from 20 day simple moving average is 6.37% whereas its distance from 50 day simple moving average is 11.27% along with 11.70% distance from 200 day simple moving average.
An important factor to consider when evaluating a stock’s current and future value are the 52 week price high and low levels. Abbott Laboratories (NYSE:ABT) shares were trading -0.44% below from the 52-week high mark of $45.21 and +24.78% above from the 52-week bottom of $36.07. The stock hit its 52-week high price on 08/02/16, and 52-week low price on 06/27/16.
When we have a peek on stock’s historical trends we come to know that, the stock has climbed 4.14% in the past one week and soared 11.25% during previous one month drive, the stock went up 12.16% during past quarter. In the last six months the stock’s performance soared 3.05% while yearly performance of the company advanced 17.85%. The company’s year to date (YTD) performance is at 17.94%.
Average true range (ATR-14) of the company sets at 0.62, along with its weekly and monthly volatility of 1.43%, 1.45% respectively. Beta value of the stock stands at 1.43.